{"product_id":"carfilzomib-карфилзомиб","title":"Carfilzomib        карфилзомиб.","description":"\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003e\u003cspan\u003eCarfilzomib\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e is a proteasome inhibitor and targeted anticancer medicine used primarily in the treatment of \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003emultiple myeloma\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e. It works by inhibiting the proteasome, a cellular protein-degradation system, which can lead to the accumulation of proteins within malignant plasma cells and ultimately inhibit their growth and survival.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003e\u003cspan\u003eIndications:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Carfilzomib is used in certain treatment regimens for adults with multiple myeloma, including patients who have received prior therapies. It may be administered alone or in combination with other anticancer medicines, depending on the approved treatment regimen.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003e\u003cspan\u003eDosage form:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Powder or lyophilized cake for preparation of a solution for \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eintravenous infusion\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003e\u003cspan\u003eAdministration:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Administered intravenously by a qualified healthcare professional. The dosage and infusion schedule depend on the treatment regimen and the patient's clinical condition.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003e\u003cspan\u003ePossible adverse effects:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e May include fatigue, nausea, anemia, thrombocytopenia, neutropenia, diarrhea, fever, and shortness of breath. Serious risks can include cardiac complications, hypertension, kidney problems, infusion-related reactions, and tumor lysis syndrome.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eImportant:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Carfilzomib is a prescription oncology medicine and should be administered under appropriate medical supervision with monitoring of blood counts, kidney function, cardiovascular status, and other relevant parameters.\u003c\/span\u003e\u003c\/p\u003e","brand":"XOMEDS","offers":[{"title":"Default Title","offer_id":45405494444075,"sku":null,"price":0.0,"currency_code":"AMD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0701\/3528\/3755\/files\/2025-12-2571-560x560.jpg?v=1789727724","url":"https:\/\/xomeds.com\/es\/products\/carfilzomib-%d0%ba%d0%b0%d1%80%d1%84%d0%b8%d0%bb%d0%b7%d0%be%d0%bc%d0%b8%d0%b1","provider":"XOMEDS","version":"1.0","type":"link"}